The head of the FDA will appear before Congress today to answer questions about the nationwide baby formula shortage.
Robert Calif is set to explain why his agency waited months to inspect an Abbott Nutrition facility in Michigan, despite reports of bacteria found in Abbott products.
Califf says logistical issues and the COVID-19 pandemic were factors in the delay.
The bacteria led to infections in some infants, leading to hospitalizations and two deaths, which eventually resulted in the closure of the facility and a recall of products in February.
The closure and recall spawned a major shortage, prompting parents to hunt for scarce supplies in stores.
Abbott and the FDA have reached an agreement to reopen the plant next week after undergoing outside safety audits.